LHLabcorp
Labcorp® Holdings Inc. is a global leader of innovative and comprehensive laboratory services that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. 10-K, Item 1
- Headquarters
- Burlington, NC
- CEO
- Adam H. Schechter
- Next results
- around Feb 16, 2027
What LH's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Facts only; most of these sales are routine, such as selling shares from vesting stock awards.
Trading plans adopted or ended
7 plans still running: Peter J. Wilkinson, Adam H. Schechter, Kerrii B. Anderson, Jonathan C. Meltzer, Kathryn W. Kyle, Bryan T. Vaughn.
| Insider | What | Date | Shares | Runs to | Reported in |
|---|---|---|---|---|---|
| Peter J. Wilkinson Senior Vice President, Chief Accounting Officer |
Adopted 10b5-1 plan | Aug 6, 2026 | up to -2,177 | Apr 30, 2027 | 10-Q Oct 30, 2026 |
| Adam H. Schechter President and Chief Executive Officer |
Adopted 10b5-1 plan | Aug 3, 2026 | up to -45,455 | Aug 27, 2027 | 10-Q Oct 30, 2026 |
| Kerrii B. Anderson Director |
Adopted 10b5-1 plan | May 18, 2026 | up to -3,000 | Aug 10, 2027 | 10-Q Aug 5, 2026 |
| Jonathan C. Meltzer Executive Vice President, Chief Operations Officer |
Adopted 10b5-1 plan | May 7, 2026 | up to -1,178 | Dec 31, 2027 | 10-Q Aug 5, 2026 |
| Kathryn W. Kyle Executive Vice President, Chief Legal Officer and Corporate Secretary |
Adopted 10b5-1 plan | Mar 9, 2026 | up to 195 | Apr 9, 2027 | 10-Q May 4, 2026 |
| Bryan T. Vaughn Executive Vice President, Diagnostics |
Adopted 10b5-1 plan | Mar 8, 2026 | up to -2,813 | May 7, 2027 | 10-Q May 4, 2026 |
| Peter J. Wilkinson Senior Vice President, Chief Accounting Officer |
Adopted 10b5-1 plan | Nov 17, 2025 | up to 2,157 | Oct 30, 2026 | 10-K Feb 24, 2026 |
| Adam H. Schechter President and Chief Executive Officer |
Adopted 10b5-1 plan | May 8, 2025 | up to 27,273 | Nov 20, 2026 | 10-Q Aug 1, 2025 |
| Kerrii B. Anderson Director |
Adopted 10b5-1 plan | Mar 6, 2025 | up to 4,500 | Jan 31, 2026 | 10-Q Apr 29, 2025 |
| Amy B. Summy Chief Marketing Officer |
Adopted 10b5-1 plan | Nov 26, 2024 | up to 1,234 | Nov 14, 2025 | 10-K Feb 25, 2025 |
| Mark S. Schroeder President, Diagnostics Laboratories and Chief Operations Officer |
Adopted 10b5-1 plan | Nov 26, 2024 | up to 76 | Nov 7, 2025 | 10-K Feb 25, 2025 |
| Amy B. Summy Chief Marketing Officer |
Adopted plan | Dec 7, 2023 | up to 4,916 | 116 days | 10-K Feb 26, 2024 |
| Mark S. Schroeder President, Diagnostics Laboratories andChief Operations Officer |
Adopted plan | Dec 7, 2023 | up to 2,119 | 365 days | 10-K Feb 26, 2024 |
| Adam H. Schechter | Adopted plan | – | up to 27,276 | – | 10-Q Oct 29, 2024 |
| Kerrii B. Anderson Director |
Adopted plan | – | up to 3,000 | – | 10-Q Aug 2, 2024 |
From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 4, 2023.
Form 144 notices of planned sales
| Filed | Seller | Shares | Value | Shares came from | 10b5-1 plan | Form 4 sales after |
|---|---|---|---|---|---|---|
| Nov 4, 2026 | Bailey Megan D. Former Officer |
3,035 | $1,096,121 | Stock Option Exercise | none given | none found |
| Nov 3, 2026 | Vaughn Bryan T Officer |
306 | $108,232 | Restricted Stock Vesting | adopted Mar 8, 2026 | 306 shares from Nov 3, 2026 |
| Oct 30, 2026 | Parham Richelle P Director |
1,078 | $389,395 | Restricted Stock Vesting | none given | 1,078 shares from Oct 30, 2026 |
| Aug 17, 2026 | KERRII B ANDERSON Director |
3,000 | $954,390 | Restricted Stock Awards | adopted May 18, 2026 | 3,000 shares from Aug 17, 2026 |
| Aug 11, 2026 | Schechter Adam H Officer, Director |
4,669 | $1,495,808 | Restricted Stock Vesting | adopted May 8, 2025 | 4,669 shares from Aug 11, 2026 |
| Aug 4, 2026 | Summy Amy B. Officer |
924 | $283,428 | Restricted Stock Vesting; Stock Option Exercise | none given | 924 shares from Aug 4, 2026 |
| Jul 2, 2026 | Kyle Kathryn W Officer |
92 | $26,329 | Restricted Stock Vesting | adopted Mar 9, 2026 | 92 shares from Jul 2, 2026 |
| Jul 2, 2026 | Vaughn Bryan T Officer |
234 | $66,968 | Restricted Stock Vesting | adopted Mar 8, 2026 | 234 shares from Jul 2, 2026 |
| Jul 1, 2026 | van der Vaart Sandra D Former Officer |
7,138 | $2,002,066 | Stock Option Exercise | none given | none found |
| Jun 8, 2026 | Kyle Kathryn W Officer |
762 | $201,084 | Restricted Stock Vesting | adopted Mar 9, 2026 | 854 shares from Jun 8, 2026 |
| May 11, 2026 | Schechter Adam H Officer, Director |
5,903 | $1,502,314 | Restricted Stock Vesting | adopted May 8, 2025 | 5,903 shares from May 11, 2026 |
| May 6, 2026 | van der Vaart Sandra D Former Officer |
6,238 | $1,601,649 | ESPP Purchase; Restricted Stock Vesting | none given | none found |
| Mar 27, 2026 | Meltzer Jonathan C Officer |
839 | $224,055 | Restricted Stock Vesting | adopted Dec 9, 2025 | none found |
| Mar 3, 2026 | Schechter Adam H Officer, Director |
8,705 | $2,437,047 | Restricted Stock Vesting | none given | none found |
| Feb 27, 2026 | van der Vaart Sandra D Officer |
548 | $156,000 | Restricted Stock Vesting | none given | none found |
| Feb 24, 2026 | Caveney Brian J Officer |
1,500 | $429,458 | Restricted Stock Vesting | none given | none found |
| Feb 12, 2026 | Meltzer Jonathan C Officer |
87 | $25,267 | Restricted Stock Vesting | adopted Dec 9, 2025 | none found |
| Feb 11, 2026 | Schechter Adam H Officer, Director |
5,273 | $1,499,536 | Restricted Stock Vesting | adopted May 8, 2025 | none found |
| Feb 10, 2026 | Meltzer Jonathan C Officer |
91 | $25,188 | Restricted Stock Vesting | adopted Dec 9, 2025 | none found |
| Feb 9, 2026 | Meltzer Jonathan C Officer |
88 | $24,247 | Restricted Stock Vesting | adopted Dec 9, 2025 | none found |
| Nov 12, 2025 | Schechter Adam H Officer, Director |
5,745 | $1,509,499 | Restricted Stock Vesting | adopted May 8, 2025 | none found |
| Oct 31, 2025 | Parham Richelle P Director |
7,009 | $1,782,273 | Restricted Stock Vesting | none given | none found |
From the Form 144 XML filed with the SEC, since Oct 31, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.
Work on LH in a spreadsheet:
Excel workbook (a sheet per section, ten years by column, charts, links to the filings) ·
CSV.
For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/LH/export.csv") into a cell.